Australia Breaking News

Noumi (ASX:NOU) enters a binding agreement with major shareholder Arrovest for a takeover valued at $737 million.

Lumos Diagnostics (ASX:LDX) secured a FebriDx rollout across 30 US urgent care sites handling 200,000 annual patient visits.

Pharmaceutical manufacturer IDT Australia (ASX:IDT) upgraded its financial year 2026 revenue guidance to $16.8 million.

Mining investment firm Lion Selection Group (ASX:LSX) committed to invest in a $4 million fundraising placement.

The Bureau of Meteorology has declared a "very strong" El Nino, warning it could be the most severe in decades. Fitch Ratings says Australia's utilities and agriculture sectors are among the most exposed, with hotter and drier conditions set to strain water supplies, lift electricity demand, and heighten bushfire risk. Fitch's Director for APAC Corporates Bruce Li, joins "Bloomberg: The Asia Trade" to discuss the implications for Australian firms.

New Zealand’s annual consumers' price index increased 4.1% in the 12 months to June, breaking past the central bank target.

Nine Entertainment (ASX:NEC) will cut 30 editorial roles across its major metropolitan newspapers to support a digital transition.

PIMCO Global Economic Advisor and Former Fed Vice Chair Richard Clarida expects the US Federal Reserve to be on a 'wait and see' mode when it comes to interest rate direction this year, given the Iran war and inflation dynamics in the US. He speaks with Paul Allen on "Insight with Haslinda Amin."

JSW Steel Joint MD & CEO Jayant Acharya discusses the company's growth strategy and says he expects raw material costs to decline in the coming quarters. He speaks with Paul Allen on Insight with Haslinda Amin.

Flagship Minerals (ASX:FLG) received US$4 million in cash after selling its RK Lithium Project.

Revolut secured an unrestricted Australian banking licence, committing to a $400 million investment over five years.

The Trump administration vowed to impose a fresh 50% tariff on some Canadian goods over what it said was unfair treatment of American alcohol, cars and dairy. Bloomberg's Derek Decloet discusses the implications.